NawaBio Space

Space Manufacturing · Precision Medicine

Engineering medicinethat leaves thehospital behind.

We grow pharmaceutical-grade protein crystals in microgravity, unlocking ultra-concentrated formulations that patients can inject at home instead of in a clinic.

Trusted by teams building what’s next

Helix VenturesAster CapitalLumen BioKepler HealthMeridian LabsVantage SciencesNorthstar BioCascade PartnersSolace PharmaIonixVertex PointAnchor BiotechHelix VenturesAster CapitalLumen BioKepler HealthMeridian LabsVantage SciencesNorthstar BioCascade PartnersSolace PharmaIonixVertex PointAnchor Biotech

The platform

A manufacturing platform built around one variable: crystal quality.

A research result

A repeatable process

What began as a one-off microgravity experiment is now engineered into hardware that flies, grows, and returns crystals on a fixed cadence.

A hospital-only drug

A simpler formulation

Denser, more uniform crystals raise drug concentration per dose, cutting the number of infusions a treatment plan requires.

The infusion chair

The kitchen table

A formulation stable and concentrated enough to self-inject moves chronic care out of the clinic and into daily life.

Why microgravity

Bigger, cleaner crystals than gravity allows.

01 — On Earth

Scattered, irregular

02 — In microgravity

Ordered, uniform

03 — The result

Assembled formulation

75–100µm

average crystal size

500µm+

average crystal size

3–5x

higher concentration

OnEarth,convectionandsedimentationdisturbcrystalsastheyform.Turbulencelimitshowlargeanduniformeachlatticecangrow,leavingsmaller,irregularstructuresscatteredthroughoutthesample.

Inmicrogravity,thatturbulencedisappears.Moleculesdriftintoplaceslowlyandassembleintocleaner,moreorderedlattices—farlargerandmoreuniformthananythinggrownundergravity.

Theresultisadenser,moreuniformcrystalstructure.Higherdrugloadingperdose,morepredictablerelease,andformulationsreadyforhigher-concentrationtherapies.

Benefits

What better crystals unlock downstream.

01 / 03

Ultra-high concentration

Larger crystal volume per unit mass allows formulations several times more concentrated than conventional processes, without added excipients.

0×more concentrated per dose
02 / 03

Formulation stability

More ordered crystal structures degrade more slowly, extending shelf life and easing cold-chain requirements for distribution.

0moadded shelf life
03 / 03

Controlled release

Crystal size and geometry can be tuned to shape dissolution rate, enabling less frequent dosing for chronic conditions.

0%fewer doses required

“Nawa Bio Space is bridging the gap between orbital research and life-saving terrestrial medicine — this is what translational science should look like. ”

Dr. Amara Reyes · Principal Consultant, Cascade Partners

Recognition

Milestones along the way.

2022Founded out of a university spinout programme
2023First crystallisation payload flown to orbit
2024Selected for a national growth-company cohort
2025Opened ground-based manufacturing facility
2026Presented platform results at three industry summits

Haveamoleculethatbelongsinorbit?

Tell us about your biologic and we’ll assess it for microgravity crystallisation within two weeks.